Literature DB >> 12849481

Cannabinoids on trial for multiple sclerosis.

John Zajicek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12849481     DOI： 10.1016/s1474-4422(02)00068-6

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  2 in total

Review 1.  [Palliative pain therapy, cannabinoids].

Authors:  L Radbruch; F Elsner
Journal:  Internist (Berl)       Date:  2005-10       Impact factor: 0.743

Review 2.  Cannabinoids in multiple sclerosis: do they have a therapeutic role?

Authors:  Joep Killestein; Bernard M J Uitdehaag; Chris H Polman
Journal:  Drugs       Date:  2004       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.